- tags:AAOphthalmology
Products
Alcon debuts rebranded DSLT device and surgical products
Company offers a sneak peek of its newly-named Voyager DSLT and two gas delivery system systems for retinal detachments—plus clinical updates on a new DED treatment.Products
Zeiss showcases expanded ophthalmic portfolio of digital tools
Company introduces new AI-based software solutions and highlights technologies from its Cataract and Retina Workflows as well as two new microscopes.Products
Beyeonics launches Beyeonics One ophthalmic exoscope with invisible light
First fully digital microscope of its kind includes an augmented reality-based headset and invisible infrared illumination.Pipeline
Beacon Therapeutics reports positive 24-month phase 2 XLRP gene therapy data
Latest findings demonstrate AGTC-501 to be generally safe and well-tolerated, with a 57% response rate noted among high-dose-treated eyes.Research
AAO, NANOS respond to study on semaglutide-NAION connection
Recent research identified substantial risk for NAION development among diabetic and obese patients using the GLP-1 RA.Research
AAO validates teleretinal screening for effective DR detection
Teleretinal screening shown to be an accurate and cost-effective approach to DR screening.Research
Eye color-changing surgeries spark AAO warning
Academy alerts consumers of potential risks associated with iris implant surgery and keratopigmentation.Products
Lumenis launches OptiPLUS radio frequency device for DED
The first dual frequency radio frequency device is designed as a complement to the novel OptiLIGHT technology.Products
Alcon's SmartCataract cloud-based app now commercially available
Platform is the first and only device of its kind, integratable with any phaco system.Events
Exhibit hall highlights from AAO: Day 3
Michael Ammar, MD, shares his final takeaways from the Expo floor at AAO.Research
Revisiting ocular antibiotic resistance with the ARMOR study
Updated findings explore the methicillin resistance of endophthalmitis isolates against common antibiotics.Pipeline
Focusing in: Surgical innovation highlights at AAO
Eric Donnenfeld, MD, FAAO, FACS, shares clinical updates on two innovative technologies and his pick for a must-attend session.Products
Zeiss launches PROSPARA cloud-based software solution
Company is introducing a broad range of digital tools and updates at AAO 2023.Pipeline
Positive 1-year data reported in ALTITUDE gene therapy trial
Ongoing phase 2 trial reports potential for one-time injection in managing DR.Research
Pediatric sickle cell disease study reports surprising ophthalmic findings
Largest retrospective review of sickle cell disease patients uncovers critical need for regular screenings.Research
Clinical perspective from AAO: Day 2
Michael Ammar, MD, offers a clinical look at the day’s top sessions and key research, including big news from two FDA-approved treatments.Products
Two-year data reported for GATHER2 study on Izervay
Phase 3 study results indicate a continued reduction in GA lesion growth.Research
Three-year data supports extended treatment of Syfovre for GA
Phase 3 GALE study results indicate a continued reduction in GA lesion growth.Products
Centricity Vision launches ZEPTOLink IOL Positioning System
Platform is the first and only device of its kind, integratable with any phaco system.Products